Already at the end of the 20th century, the first 3D printed products were produced in the medical and pharmaceutical sector. The first was the production of prostheses, while today additive manufacturing is an important alternative production method for prototypes, small series and low-cost production.
In the field of pharmaceuticals, on the other hand, 3D printing is still in its early stages and has not yet been able to fully establish itself. A decisive breakthrough for additive manufacturing was the approval of an epilepsy drug by the U.S. Food and Drug Administration (FDA) in 2015. This is the first and only 3D printed approved drug to date.
You want to learn how the manufacturing of the product works and which advantages additive manufacturing can have in the pharmaceutical industry? Then take a look at our latest arcoro SNAPS. We have summarised the most exciting information for you in a compact form.